《表2 两组不良反应发生情况比较[n, (%) ]Tab.2 The incidence of adverse reactions in two groups[n, (%) ]》
![《表2 两组不良反应发生情况比较[n, (%) ]Tab.2 The incidence of adverse reactions in two groups[n, (%) ]》](http://bookimg.mtoou.info/tubiao/gif/HELJ201822020_04400.gif)
提示：宽带有限、当前游客访问压缩模式
乙组不良反应发生率为0，甲组为16.7%，差异有统计学意义（P<0.05），见表2。
| 图表编号 | XD0024838900 严禁用于非法目的 |
|---|---|
| 绘制时间 | 2018.11.01 |
| 作者 | 徐文华 |
| 绘制单位 | 中山大学肿瘤防治中心 |
| 更多格式 | 高清、无水印（增值服务） |
![表2 患者化疗过程中不良反应发生率[例 (%) ]Tab 2 The incidence of adverse reactions in patients undergo-ing chemotherapy[case (%) ]](http://bookimg.mtoou.info/tubiao/gif/ZGYZ201901017_06700.gif)
![表2 两组患者不良反应比较[n (%) ]Tab.2 Comparison of adverse reactions between two groups[n (%) ]](http://bookimg.mtoou.info/tubiao/gif/ZAZF201901014_08600.gif)
![表2 组间不良反应发生情况对比[n (%) ]Tab 2 Comparison of adverse reactions between groups[n (%) ]](http://bookimg.mtoou.info/tubiao/gif/YPPJ201902008_04100.gif)
相关图表
- 《表2 患者化疗过程中不良反应发生率[例 (%) ]Tab 2 The incidence of adverse reactions in patients undergo-ing chemotherapy[case (%) ]》2019.01.15
- 《表2 两组患者不良反应比较[n (%) ]Tab.2 Comparison of adverse reactions between two groups[n (%) ]》2019.02.25
- 《表2 两组患儿术后不良反应发生情况比较 (n/%) Tab 2 Comparison of postoperative adverse reactions between the two groups (n/%)》2019.01.28
- 《表2 组间不良反应发生情况对比[n (%) ]Tab 2 Comparison of adverse reactions between groups[n (%) ]》2019.01.28
- 《表3 两组患者用药不良反应发生率对比详情 (例/%) Tab 3 Details of the incidence of adverse drug reactions between the two groups (cases/%)》2019.01.08
- 《表6 3组患者不良反应发生情况比较Tab.6 Comparison of the incidence of adverse reactions in the three groups》2019.01.05
- 《表2 插管情况及不良反应的比较[n (%) ]Tab 2 Comparison of intubation and adverse reactions[n (%) ]》2019.01.20
- 《表4 两组患者的不良反应发生率比较Tab 4 The incidence of adverse reactions in the two groups of patients》2019.01.20
- 《表3 两组患者不良反应发生率比较[n (%) ]Tab 3 Comparison of the incidence of adverse reactions between patients in two groups[n (%) ]》2019.01.20
- 《表2 两组患者不良反应的比较n Tab.2 Comparison of adverse reactions between the two groups n》2019.03.20
- 《表3 两组患者不良反应发生率比较n (%) Tab.3Comparison of the incidence of adverse reactions in the two groups n (%)》2019.03.05
- 《表2 两组患者化疗不良反应比较n Tab.2The incidence rate of adverse reactions in patients with chemo-therapy between the two groups n》2019.01.20
- 《表3 两组病人住院时间、不良反应发生率及复发率情况分析 (n, %) Tab.3 Analysis of hospitalization time, incidence of adverse reactions and recurrence》2019.02.01
- 《表3 两组患者术后不良反应发生率比较 (n (%) ) Table 3 Comparison of the incidence of postoperative adverse reactions in the two groups (n》2018.09.25
- 《表2 各组患者不良反应发生率比较 (n=35, %) Tab.2 Comparison of the incidence of adverse reactions among the three groups (n=35, %)》2018.01.01
- 《表3 三组患者不良反应发生率比较Tab 3 Comparison of adverse effects incidence among three groups of cases》2018.08.20
- 《表6 两组术后不良反应发生情况比较Tab 6 Comparison of adverse reactions after operation between the two groups》2018.02.20
- 《表3 两组患者不良反应发生率对比 (n) Table 3 Incidence of adverse reactions in the two groups (n)》2018.01.25
- 《表3 两组不良反应发生情况比较 (n) Table 3 Comparison of adverse events in both groups (n)》2018.01.25
- 《表4 不良反应发生率比较 (n) Table 4 Adverse reactions incidence comparison (n)》2018.01.25